Patient Agreement Form and Medication Abortion Knowledge

Completed · Not applicable

Conditions studied: Medication Abortion, Health Knowledge Attitudes and Practice, Pregnant People

In brief

This study evaluates whether exposure to the U.S. Food and Drug Administration (FDA)-required Patient Agreement Form (PAF) for mifepristone improves patient knowledge about medication abortion. Participants seeking medication abortion at clinical sites in the United States were randomized to complete a knowledge assessment either before or after reviewing and signing the PAF. The primary objective was to assess whether exposure to the PAF improves knowledge related to medication abortion, including medication use, effectiveness, risks, and when to seek medical care.

Key facts

Study ID

NCT07604675

Run by

University of California, San Francisco

People needed

637

Starts

2025-01-15

Expected to finish

2025-10-17

Last updated by the study team

2026-05-22

Who can join

Age: 15 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Aged 15 years or older
• Able to read and speak English or Spanish
• Seeking medication abortion or receiving mifepristone for miscarriage management

You may not qualify if…

• Does not meet inclusion criteria
• Unable or unwilling to provide informed consent

Where it is running

• Planned Parenthood Northern California — San Francisco, California, United States
• Planned Parenthood Rocky Mountain — Denver, Colorado, United States
• Choices — Carbondale, Illinois, United States
• Aria Medical Center — Wichita, Kansas, United States
• Planned Parenthood North Central States — Saint Paul, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.